• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病:与糖尿病患者相关的肾脏疾病。

Diabetic kidney disease: the kidney disease relevant to individuals with diabetes.

作者信息

Kanasaki Keizo, Ueki Kohjiro, Nangaku Masaomi

机构信息

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, 693-8501, Japan.

The Center for Integrated Kidney Research and Advance, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, 693-8501, Japan.

出版信息

Clin Exp Nephrol. 2024 Dec;28(12):1213-1220. doi: 10.1007/s10157-024-02537-z. Epub 2024 Jul 20.

DOI:10.1007/s10157-024-02537-z
PMID:39031296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11621156/
Abstract

In individuals with diabetes, chronic kidney disease (CKD) is a major comorbidity. However, it appears that there is worldwide confusion regarding which term should be used to describe CKD complicated with diabetes: diabetic nephropathy, diabetic kidney disease (DKD), CKD with diabetes, diabetes and CKD, etc. Similar confusion has also been reported in Japan. Therefore, to provide clarification, the Japanese Diabetes Society and the Japanese Society of Nephrology collaborated to update the corresponding Japanese term to describe DKD and clearly define the concept of DKD. In this review, we briefly described the history of kidney complications in individuals with diabetes and the Japanese definition of the DKD concept and provided our rationale for these changes.

摘要

在糖尿病患者中,慢性肾脏病(CKD)是一种主要的合并症。然而,对于应该使用哪个术语来描述合并糖尿病的CKD,全球似乎存在混淆:糖尿病肾病、糖尿病性肾脏疾病(DKD)、合并糖尿病的CKD、糖尿病与CKD等。在日本也有类似的混淆情况报道。因此,为了澄清,日本糖尿病学会和日本肾脏病学会合作更新了描述DKD的相应日语术语,并明确定义了DKD的概念。在这篇综述中,我们简要描述了糖尿病患者肾脏并发症的历史以及DKD概念的日语定义,并阐述了这些变化的理由。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/12733d6a2e8c/10157_2024_2537_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/8215c4a0d785/10157_2024_2537_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/7005dadc44c3/10157_2024_2537_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/12733d6a2e8c/10157_2024_2537_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/8215c4a0d785/10157_2024_2537_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/7005dadc44c3/10157_2024_2537_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4e/11621156/12733d6a2e8c/10157_2024_2537_Fig3_HTML.jpg

相似文献

1
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes.糖尿病肾病:与糖尿病患者相关的肾脏疾病。
Clin Exp Nephrol. 2024 Dec;28(12):1213-1220. doi: 10.1007/s10157-024-02537-z. Epub 2024 Jul 20.
2
'DKD' as the kidney disease relevant to individuals with diabetes.“糖尿病肾病”是与糖尿病患者相关的肾脏疾病。
Diabetol Int. 2024 Aug 6;15(4):673-676. doi: 10.1007/s13340-024-00747-0. eCollection 2024 Oct.
3
Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.分析糖尿病及肾脏病变患者尿液的拉曼光谱差异。
PeerJ. 2023 Feb 27;11:e14879. doi: 10.7717/peerj.14879. eCollection 2023.
4
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.非白蛋白尿性糖尿病肾病与 2 型糖尿病全因死亡率及心血管和肾脏结局的关系:来自香港糖尿病生物库的研究结果。
Am J Kidney Dis. 2022 Aug;80(2):196-206.e1. doi: 10.1053/j.ajkd.2021.11.011. Epub 2022 Jan 6.
5
Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.糖尿病肾病患者中糖尿病和慢性肾脏病对神经病变发展的相对贡献。
Clin Neurophysiol. 2019 Nov;130(11):2088-2095. doi: 10.1016/j.clinph.2019.08.005. Epub 2019 Aug 22.
6
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.成人糖尿病肾病高血糖管理的临床实践指南
Diabet Med. 2022 Apr;39(4):e14769. doi: 10.1111/dme.14769. Epub 2022 Jan 26.
7
[Status Quo and Research Progress in Diagnosis and Treatment of Patients With Diabetes Mellitus and Chronic Kidney Disease].糖尿病合并慢性肾脏病患者的诊断与治疗现状及研究进展
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Dec 30;45(6):987-996. doi: 10.3881/j.issn.1000-503X.15469.
8
Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.中国中部城市人口中慢性肾脏病和糖尿病肾病的患病率及相关危险因素:一项横断面调查。
BMC Nephrol. 2020 Apr 3;21(1):115. doi: 10.1186/s12882-020-01761-5.
9
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.患有糖尿病肾病和非糖尿病肾病的患者慢性肾脏病进展的预后和危险因素:一项前瞻性队列 CKD-ROUTE 研究。
Ren Fail. 2022 Dec;44(1):1309-1318. doi: 10.1080/0886022X.2022.2106872.
10
Nidogen-1 could play a role in diabetic kidney disease development in type 2 diabetes: a genome-wide association meta-analysis.层粘连蛋白聚糖-1 可能在 2 型糖尿病中的糖尿病肾病发展中发挥作用:一项全基因组关联荟萃分析。
Hum Genomics. 2022 Oct 21;16(1):47. doi: 10.1186/s40246-022-00422-y.

引用本文的文献

1
Expanding the therapeutic frontier: esaxerenone in hypertensive patients with CKD and albuminuria.拓展治疗前沿:依普利酮用于慢性肾脏病合并白蛋白尿的高血压患者
Hypertens Res. 2025 Aug 21. doi: 10.1038/s41440-025-02313-w.
2
Carvedilol-loaded self-nanoemulsifying drug delivery system target diabetic nephropathy: preclinical evidence of antioxidant and antifibrotic effects.载有卡维地洛的自纳米乳化药物递送系统靶向糖尿病肾病:抗氧化和抗纤维化作用的临床前证据
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 18. doi: 10.1007/s00210-025-04356-9.
3
Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney disease.

本文引用的文献

1
Dipeptidyl peptidase-4 inhibitor-related renal disease.二肽基肽酶-4 抑制剂相关肾脏疾病。
J Diabetes Complications. 2023 Oct;37(10):108590. doi: 10.1016/j.jdiacomp.2023.108590. Epub 2023 Sep 1.
2
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients.内源性腺嘌呤介导糖尿病模型中的肾脏损伤,并可预测患者的糖尿病肾病。
J Clin Invest. 2023 Oct 16;133(20):e170341. doi: 10.1172/JCI170341.
3
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes.
内皮细胞血管生成素样蛋白4缺失引起的代谢重编程可预防糖尿病肾病。
bioRxiv. 2025 May 12:2025.05.08.652142. doi: 10.1101/2025.05.08.652142.
4
Natural products in treating diabetic kidney disease: a visualized bibliometric analysis.天然产物在治疗糖尿病肾病中的应用:可视化文献计量分析
Front Pharmacol. 2025 May 19;16:1522074. doi: 10.3389/fphar.2025.1522074. eCollection 2025.
5
The PKM2 activator TEPP-46 suppresses cellular senescence in hydrogen peroxide-induced proximal tubular cells and kidney fibrosis in CD-1 mice.丙酮酸激酶M2激活剂TEPP-46可抑制过氧化氢诱导的近端肾小管细胞衰老以及CD-1小鼠的肾纤维化。
J Diabetes Investig. 2025 Apr;16(4):598-607. doi: 10.1111/jdi.14397. Epub 2025 Jan 22.
6
Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention.糖尿病肾病进展及针刺干预机制的研究进展
Int J Gen Med. 2024 Nov 27;17:5593-5609. doi: 10.2147/IJGM.S490049. eCollection 2024.
7
'DKD' as the kidney disease relevant to individuals with diabetes.“糖尿病肾病”是与糖尿病患者相关的肾脏疾病。
Diabetol Int. 2024 Aug 6;15(4):673-676. doi: 10.1007/s13340-024-00747-0. eCollection 2024 Oct.
SGLT2 抑制剂可减轻青少年 2 型糖尿病患者肾小管代谢和 mTORC1 紊乱。
J Clin Invest. 2023 Mar 1;133(5):e164486. doi: 10.1172/JCI164486.
4
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
5
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2022慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008.
6
Advance Care Planning Coaching in CKD Clinics: A Pragmatic Randomized Clinical Trial.慢性肾脏病诊所中的预先护理计划指导:一项实用随机临床试验
Am J Kidney Dis. 2022 May;79(5):699-708.e1. doi: 10.1053/j.ajkd.2021.08.019. Epub 2021 Oct 12.
7
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective.基于聚类分析的成年发病型糖尿病分类的血糖控制和预防糖尿病并发症的新策略:一个视角。
Diabetes Res Clin Pract. 2021 Oct;180:109067. doi: 10.1016/j.diabres.2021.109067. Epub 2021 Sep 23.
8
Renal protection in chronic heart failure: focus on sacubitril/valsartan.慢性心力衰竭的肾脏保护:关注沙库巴曲缬沙坦。
Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):445-452. doi: 10.1093/ehjcvp/pvab030.
9
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.基于病理生理学的 2 型糖尿病高危个体亚表型分型。
Nat Med. 2021 Jan;27(1):49-57. doi: 10.1038/s41591-020-1116-9. Epub 2021 Jan 4.
10
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.新型糖尿病和非糖尿病慢性肾脏病进展的风险因素:来自慢性肾脏病预后质量倡议(CRIC)研究的结果。
Am J Kidney Dis. 2021 Jan;77(1):56-73.e1. doi: 10.1053/j.ajkd.2020.07.011. Epub 2020 Aug 28.